MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

LeMaitre Vascular Inc

Gesloten

SectorGezondheidszorg

84.82 1.61

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

81.92

Max

85.32

Belangrijke statistieken

By Trading Economics

Inkomsten

43K

11M

Verkoop

898K

56M

K/W

Sectorgemiddelde

43.026

63.778

EPS

0.49

Dividendrendement

0.96

Winstmarge

20.073

Werknemers

651

EBITDA

4.6M

20M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+24.27% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.96%

2.39%

Volgende Winsten

1 mei 2025

Volgende dividenddatum

29 mei 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-401M

1.9B

Vorige openingsprijs

83.21

Vorige sluitingsprijs

84.82

Nieuwssentiment

By Acuity

50%

50%

173 / 386 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

LeMaitre Vascular Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

1 apr 2025, 23:15 UTC

Belangrijke Marktbewegers

Hims & Hers Adds Eli Lilly's Zepbound in Expansion of Weight-Loss Offerings -- 2nd Update

1 apr 2025, 23:46 UTC

Marktinformatie

Market Grapples With Valuing Goodman's Data Centers -- Market Talk

1 apr 2025, 23:44 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

1 apr 2025, 23:44 UTC

Marktinformatie

Global Equities Roundup: Market Talk

1 apr 2025, 23:44 UTC

Marktinformatie

Nikkei May Trade Rangebound Amid U.S. Tariff Uncertainty -- Market Talk

1 apr 2025, 23:43 UTC

Marktinformatie

Gold Steady, Underpinned by Signs of Chinese Buying Activity -- Market Talk

1 apr 2025, 23:11 UTC

Top Nieuws

Risk Off Trade Is Getting Crowded. It's More Worry Than Panic. -- Barrons.com

1 apr 2025, 23:02 UTC

Marktinformatie

New Zealand May Be Measuring Stick for Trade-War Fallout -- Market Talk

1 apr 2025, 22:31 UTC

Top Nieuws

Wilbur Ross Has Thoughts on Trump's Tariffs -- Barrons.com

1 apr 2025, 22:26 UTC

Marktinformatie

RBA's Focus on What It Doesn't Know Boosts May Cut Odds -- Market Talk

1 apr 2025, 21:47 UTC

Top Nieuws

Wilbur Ross Has Thoughts on Trump's Tariffs -- Barrons.com

1 apr 2025, 21:32 UTC

Top Nieuws

Hooters' Bankruptcy Is the Latest Sign of Trouble for Restaurants -- Barrons.com

1 apr 2025, 21:06 UTC

Marktinformatie

Mexican Remittances See Slow Start to the Year -- Market Talk

1 apr 2025, 21:00 UTC

Marktinformatie

ESG Roundup: Market Talk

1 apr 2025, 20:50 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Financial Services Roundup: Market Talk

1 apr 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

1 apr 2025, 20:47 UTC

Top Nieuws

Boeing Stock Drops. Why Lower 737 MAX Production Report Wasn't Quite Right. -- Barrons.com

1 apr 2025, 20:47 UTC

Top Nieuws

BYD Will Beat Tesla Two Ways This Quarter -- Barrons.com

1 apr 2025, 20:20 UTC

Top Nieuws

Trump's 'Liberation Day' Tariffs Loom; Treasury Yields Fall -- WSJ

1 apr 2025, 20:15 UTC

Acquisities, Fusies, Overnames

Eaton Completes Acquisition Of Fibrebond >ETN

1 apr 2025, 20:11 UTC

Marktinformatie

Altria Stock Seen Overvalued Amid Steep Volume Losses -- Market Talk

1 apr 2025, 20:07 UTC

Acquisities, Fusies, Overnames

Johnson & Johnson Intends to Complete Its Acquisition of Intra-Cellular Therapies on or Around April 2 >JNJ

1 apr 2025, 20:00 UTC

Top Nieuws

Americans Are Worried About Tariffs. Consumer Stocks Could Take a Hit. -- Barrons.com

1 apr 2025, 19:46 UTC

Top Nieuws

Visa, American Express Bidding to Win Apple Credit-Card Network, Sources Say -- WSJ

1 apr 2025, 19:43 UTC

Marktinformatie

Oil Rally Loses Momentum Ahead of U.S. Tariff Plans -- Market Talk

1 apr 2025, 19:17 UTC

Top Nieuws

Meta's Head of AI Research to Resign Amid Computing Push -- Update

1 apr 2025, 19:13 UTC

Marktinformatie

U.S. Natural Gas Futures Give Back Gains -- Market Talk

1 apr 2025, 19:03 UTC

Marktinformatie

Don't Rush Into Trade Talks With U.S., Canadian Experts Advise Lawmakers -- Market Talk

1 apr 2025, 19:00 UTC

Marktinformatie

Gold Slips Ahead of Tariff Day -- Market Talk

1 apr 2025, 18:54 UTC

Marktinformatie

Mexican Manufacturing PMIs Reflect Tariff Threats -- Market Talk

Peer Vergelijking

Prijswijziging

LeMaitre Vascular Inc Prognose

Koersdoel

By TipRanks

24.27% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 105.83 USD  24.27%

Hoogste 115 USD

Laagste 95 USD

Gebaseerd op 9 Wall Street-analisten die 12-maands prijsdoelen bieden voor LeMaitre Vascular Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

9 ratings

4

Buy

5

Hold

0

Sell

Technische score

By Trading Central

83.7655 / 85.39Steun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

173 / 386 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over LeMaitre Vascular Inc

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.